BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 11397088)

  • 1. Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries.
    Burmester J; Spinelli S; Pugliese L; Krebber A; Honegger A; Jung S; Schimmele B; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):671-85. PubMed ID: 11397088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of framework residues H6, H7 and H10 in antibody heavy chains: experimental evidence for a new structural subclassification of antibody V(H) domains.
    Jung S; Spinelli S; Schimmele B; Honegger A; Pugliese L; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):701-16. PubMed ID: 11397090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the anti-His tag antibody 3D5 single-chain fragment complexed to its antigen.
    Kaufmann M; Lindner P; Honegger A; Blank K; Tschopp M; Capitani G; Plückthun A; Grütter MG
    J Mol Biol; 2002 Apr; 318(1):135-47. PubMed ID: 12054774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The primary structure and specificity determining residues displayed by recombinant salmon antibody domains.
    Solem ST; Brandsdal BO; Smalås A; Jørgensen TØ
    Mol Immunol; 2004 Apr; 40(18):1347-60. PubMed ID: 15072853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site.
    Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD
    J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The three-dimensional structure of a complex of a murine Fab (NC10. 14) with a potent sweetener (NC174): an illustration of structural diversity in antigen recognition by immunoglobulins.
    Guddat LW; Shan L; Broomell C; Ramsland PA; Fan Z; Anchin JM; Linthicum DS; Edmundson AB
    J Mol Biol; 2000 Sep; 302(4):853-72. PubMed ID: 10993728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold.
    Desiderio A; Franconi R; Lopez M; Villani ME; Viti F; Chiaraluce R; Consalvi V; Neri D; Benvenuto E
    J Mol Biol; 2001 Jul; 310(3):603-15. PubMed ID: 11439027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
    Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
    Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
    J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
    Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
    Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection.
    Schier R; Bye J; Apell G; McCall A; Adams GP; Malmqvist M; Weiner LM; Marks JD
    J Mol Biol; 1996 Jan; 255(1):28-43. PubMed ID: 8568873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly specific anti-estradiol antibodies: structural characterisation and binding diversity.
    Monnet C; Bettsworth F; Stura EA; Le Du MH; Ménez R; Derrien L; Zinn-Justin S; Gilquin B; Sibaï G; Battail-Poirot N; Jolivet M; Ménez A; Arnaud M; Ducancel F; Charbonnier JB
    J Mol Biol; 2002 Jan; 315(4):699-712. PubMed ID: 11812141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
    Wu H; Nie Y; Huse WD; Watkins JD
    J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and characterization of single chain Fv fragments against murine recombinant prion protein from a synthetic human antibody phage display library.
    Leclerc E; Liemann S; Wildegger G; Vetter SW; Nilsson F
    Hum Antibodies; 2000; 9(4):207-14. PubMed ID: 11341174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.
    Fellouse FA; Esaki K; Birtalan S; Raptis D; Cancasci VJ; Koide A; Jhurani P; Vasser M; Wiesmann C; Kossiakoff AA; Koide S; Sidhu SS
    J Mol Biol; 2007 Nov; 373(4):924-40. PubMed ID: 17825836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody multispecificity mediated by conformational diversity.
    James LC; Roversi P; Tawfik DS
    Science; 2003 Feb; 299(5611):1362-7. PubMed ID: 12610298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural consequences of humanizing an antibody.
    Holmes MA; Foote J
    J Immunol; 1997 Mar; 158(5):2192-201. PubMed ID: 9036965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.